Pay in 4 interest-free payments of $6.39 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
IV NAD therapies are not FDA-approved , have no standardized dosing, and may cause nausea, flushing, anxiety, or tachycardia
We accept bank transfers, credit and debit cards, and purchase orders from accredited institutions, universities, and registered research organisations
Foundayo is an oral GLP-1 receptor agonist taken once daily
Expertly formulated as a comforting final step, this serum may enhance post-procedure results following aesthetic treatments such as microneedling, LED, and dermaplaning by helping promote hydration, while soothing the skin, which may contribute to optimized rejuvenation
5 In addition to the potential benefits of GLP-1 receptor agonists already mentioned, several dedicated cardiovascular outcome trials have reported positive cardiovascular and kidney outcomes with agents from the GLP-1 receptor agonist class
US$ 24.46
US$ 23.53
US$ 21.10
US$ 26.94
.png)